EverPoint Asset Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$5.34M Sell
400,000
-150,000
-27% -$2.42M 0.1% 239
2016
Q3
$10.2M Sell
550,000
-1,831,666
-77% -$32.3M 0.18% 146
2016
Q2
$29.2M Buy
2,381,666
+381,666
+19% +$2.87M 0.58% 39
2016
Q1
$13.5M Buy
+2,000,000
New +$12.8M 0.27% 97
2015
Q4
Sell
-220,000
Closed -$2.05M 484
2015
Q3
$3.96M Buy
220,000
+20,000
+10% +$459K 0.1% 250
2015
Q2
$5.95M Sell
200,000
-650,000
-76% -$16.3M 0.11% 252
2015
Q1
$18.7M Buy
850,000
+639,675
+304% +$16.2M 0.35% 78
2014
Q4
$5.77M Buy
+210,325
New +$5.12M 0.13% 232

Other funds holding EXAS

EverPoint Asset Management's EXAS Position: Q4 2016 in Review

EverPoint Asset Management reduced its Exact Sciences (EXAS) stake by 27% in Q4 2016, selling an estimated $2.42M and leaving 400,000 shares worth $5.34M. The position accounts for 0.1% of the portfolio, ranked #239.

EverPoint Asset Management first reported a position in EXAS in Q4 2014 and has held it in 8 quarters since. The position peaked at $29.2M in Q2 2016. 223 funds tracked by Wall St. Rank hold EXAS as of Q4 2016.

  • EverPoint Asset Management held 400,000 shares of Exact Sciences worth $5.34M as of Q4 2016.
  • EverPoint Asset Management sold 150,000 Exact Sciences shares in Q4 2016, an estimated $2.42M.
  • Exact Sciences made up 0.1% of EverPoint Asset Management's portfolio in Q4 2016, its #239 holding.
  • EverPoint Asset Management first reported a position in Exact Sciences in Q4 2014 and has held it in 8 quarters since.
  • EverPoint Asset Management's Exact Sciences position peaked at $29.2M in Q2 2016.
  • 223 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2016.

Based on EverPoint Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.